This Training Grant, now entering its 25th year, provides support for a unique interdisciplinary pre-doctoral and post-doctoral training program in Immunology at the Johns Hopkins University School of Medicine. The Training Grant is the core source of funding for the Graduate Program in Immunology. The mission of this Interdepartmental program is to provide students and fellows with training in cellular, biochemical, and genetic approaches to the biology of the immune response. We seek to provide trainees with the ability to identify significant research questions in immunology, to find solutions to these questions, to think broadly and creatively about biological problems, and to communicate ideas effectively to others. There are 34 faculty members who participate in the program and provide a broad range of training opportunities for students and fellows. These areas include genetic and cellular Aspects of immune development, T cell antigen recognition, immune regulation, tolerance, structural biology immune proteins, complement, innate immunity, autoimmunity, immune cell signaling, cancer immunology, IgE-mediated immunologic reactions and the host response to infection. In these areas, the training environment is enhanced by institutional strength in relevant areas of basic science and/or clinical medicine. Cross-fertilization between basic research and clinical disease studies is an important aspect of the training environment. The predoctoral program places emphasis on rigorous training in basic biochemistry and molecular and cellular biology in addition to immunology. Progress of trainees throughout the didactic and research portions of the pre-doctoral training program is monitored closely through multiple mechanisms. Post-doctoral fellows have the option of selecting laboratories that focus on basic immunology or immunologic diseases. An extensive and successful program for recruiting minority students has been implemented.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007247-30
Application #
8106109
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Prograis, Lawrence J
Project Start
1982-09-01
Project End
2013-07-31
Budget Start
2011-09-01
Budget End
2013-07-31
Support Year
30
Fiscal Year
2011
Total Cost
$654,415
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Walker-Sperling, Victoria E; Pohlmeyer, Christopher W; Veenhuis, Rebecca T et al. (2017) Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller. EBioMedicine 16:141-149
Patel, Chirag H; Powell, Jonathan D (2017) Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease. Curr Opin Immunol 46:82-88
Bettencourt, Ian A; Powell, Jonathan D (2017) Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation. J Immunol 198:999-1005
Veenhuis, Rebecca T; Astemborski, Jacquie; Chattergoon, Michael A et al. (2017) Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection. Clin Infect Dis 64:589-596
Bailey, Justin R; Flyak, Andrew I; Cohen, Valerie J et al. (2017) Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. JCI Insight 2:
Kwaa, Abena K; Goldsborough, Kennedy; Walker-Sperling, Victoria E et al. (2017) The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells. PLoS One 12:e0174516
Kates, Max; Nirschl, Thomas; Sopko, Nikolai A et al. (2017) Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer. Cancer Immunol Res 5:594-603
Kosmides, Alyssa K; Sidhom, John-William; Fraser, Andrew et al. (2017) Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth. ACS Nano 11:5417-5429
Hallowell, R W; Collins, S L; Craig, J M et al. (2017) mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis. Nat Commun 8:14208
El-Diwany, Ramy; Cohen, Valerie J; Mankowski, Madeleine C et al. (2017) Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1. PLoS Pathog 13:e1006235

Showing the most recent 10 out of 182 publications